[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Ophthalmic Cyclosporine Supply, Demand and Key Producers, 2024-2030

February 2024 | 137 pages | ID: G0D9F9021510EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Ophthalmic Cyclosporine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Ophthalmic Cyclosporine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Ophthalmic Cyclosporine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ophthalmic Cyclosporine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Ophthalmic Cyclosporine total production and demand, 2019-2030, (K Units)

Global Ophthalmic Cyclosporine total production value, 2019-2030, (USD Million)

Global Ophthalmic Cyclosporine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)

Global Ophthalmic Cyclosporine consumption by region & country, CAGR, 2019-2030 & (K Units)

U.S. VS China: Ophthalmic Cyclosporine domestic production, consumption, key domestic manufacturers and share

Global Ophthalmic Cyclosporine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)

Global Ophthalmic Cyclosporine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)

Global Ophthalmic Cyclosporine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Ophthalmic Cyclosporine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Bausch + Lomb, Teva, Mylan Pharmaceuticals, Alcon, Regenerx Biopharmaceuticals, Mimetogen Pharmaceuticals, Mitotech and Sun Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ophthalmic Cyclosporine market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Ophthalmic Cyclosporine Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Ophthalmic Cyclosporine Market, Segmentation by Type
  • Ophthalmic Cyclosporine Emulsion
  • Ophthalmic Cyclosporine Suspension
  • Ophthalmic Cyclosporine Ointment
  • Others
Global Ophthalmic Cyclosporine Market, Segmentation by Application
  • Hospital
  • Clinic
  • Others
Companies Profiled:
  • Allergan
  • Bausch + Lomb
  • Teva
  • Mylan Pharmaceuticals
  • Alcon
  • Regenerx Biopharmaceuticals
  • Mimetogen Pharmaceuticals
  • Mitotech
  • Sun Pharma
  • Otsuka Pharmaceutical
  • Santen Pharmaceutical
Key Questions Answered

1. How big is the global Ophthalmic Cyclosporine market?

2. What is the demand of the global Ophthalmic Cyclosporine market?

3. What is the year over year growth of the global Ophthalmic Cyclosporine market?

4. What is the production and production value of the global Ophthalmic Cyclosporine market?

5. Who are the key producers in the global Ophthalmic Cyclosporine market?
1 SUPPLY SUMMARY

1.1 Ophthalmic Cyclosporine Introduction
1.2 World Ophthalmic Cyclosporine Supply & Forecast
  1.2.1 World Ophthalmic Cyclosporine Production Value (2019 & 2023 & 2030)
  1.2.2 World Ophthalmic Cyclosporine Production (2019-2030)
  1.2.3 World Ophthalmic Cyclosporine Pricing Trends (2019-2030)
1.3 World Ophthalmic Cyclosporine Production by Region (Based on Production Site)
  1.3.1 World Ophthalmic Cyclosporine Production Value by Region (2019-2030)
  1.3.2 World Ophthalmic Cyclosporine Production by Region (2019-2030)
  1.3.3 World Ophthalmic Cyclosporine Average Price by Region (2019-2030)
  1.3.4 North America Ophthalmic Cyclosporine Production (2019-2030)
  1.3.5 Europe Ophthalmic Cyclosporine Production (2019-2030)
  1.3.6 China Ophthalmic Cyclosporine Production (2019-2030)
  1.3.7 Japan Ophthalmic Cyclosporine Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Ophthalmic Cyclosporine Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Ophthalmic Cyclosporine Major Market Trends

2 DEMAND SUMMARY

2.1 World Ophthalmic Cyclosporine Demand (2019-2030)
2.2 World Ophthalmic Cyclosporine Consumption by Region
  2.2.1 World Ophthalmic Cyclosporine Consumption by Region (2019-2024)
  2.2.2 World Ophthalmic Cyclosporine Consumption Forecast by Region (2025-2030)
2.3 United States Ophthalmic Cyclosporine Consumption (2019-2030)
2.4 China Ophthalmic Cyclosporine Consumption (2019-2030)
2.5 Europe Ophthalmic Cyclosporine Consumption (2019-2030)
2.6 Japan Ophthalmic Cyclosporine Consumption (2019-2030)
2.7 South Korea Ophthalmic Cyclosporine Consumption (2019-2030)
2.8 ASEAN Ophthalmic Cyclosporine Consumption (2019-2030)
2.9 India Ophthalmic Cyclosporine Consumption (2019-2030)

3 WORLD OPHTHALMIC CYCLOSPORINE MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Ophthalmic Cyclosporine Production Value by Manufacturer (2019-2024)
3.2 World Ophthalmic Cyclosporine Production by Manufacturer (2019-2024)
3.3 World Ophthalmic Cyclosporine Average Price by Manufacturer (2019-2024)
3.4 Ophthalmic Cyclosporine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Ophthalmic Cyclosporine Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Ophthalmic Cyclosporine in 2023
  3.5.3 Global Concentration Ratios (CR8) for Ophthalmic Cyclosporine in 2023
3.6 Ophthalmic Cyclosporine Market: Overall Company Footprint Analysis
  3.6.1 Ophthalmic Cyclosporine Market: Region Footprint
  3.6.2 Ophthalmic Cyclosporine Market: Company Product Type Footprint
  3.6.3 Ophthalmic Cyclosporine Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Ophthalmic Cyclosporine Production Value Comparison
  4.1.1 United States VS China: Ophthalmic Cyclosporine Production Value Comparison (2019 & 2023 & 2030)
  4.1.2 United States VS China: Ophthalmic Cyclosporine Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Ophthalmic Cyclosporine Production Comparison
  4.2.1 United States VS China: Ophthalmic Cyclosporine Production Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: Ophthalmic Cyclosporine Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Ophthalmic Cyclosporine Consumption Comparison
  4.3.1 United States VS China: Ophthalmic Cyclosporine Consumption Comparison (2019 & 2023 & 2030)
  4.3.2 United States VS China: Ophthalmic Cyclosporine Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Ophthalmic Cyclosporine Manufacturers and Market Share, 2019-2024
  4.4.1 United States Based Ophthalmic Cyclosporine Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Ophthalmic Cyclosporine Production Value (2019-2024)
  4.4.3 United States Based Manufacturers Ophthalmic Cyclosporine Production (2019-2024)
4.5 China Based Ophthalmic Cyclosporine Manufacturers and Market Share
  4.5.1 China Based Ophthalmic Cyclosporine Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Ophthalmic Cyclosporine Production Value (2019-2024)
  4.5.3 China Based Manufacturers Ophthalmic Cyclosporine Production (2019-2024)
4.6 Rest of World Based Ophthalmic Cyclosporine Manufacturers and Market Share, 2019-2024
  4.6.1 Rest of World Based Ophthalmic Cyclosporine Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Ophthalmic Cyclosporine Production Value (2019-2024)
  4.6.3 Rest of World Based Manufacturers Ophthalmic Cyclosporine Production (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World Ophthalmic Cyclosporine Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Ophthalmic Cyclosporine Emulsion
  5.2.2 Ophthalmic Cyclosporine Suspension
  5.2.3 Ophthalmic Cyclosporine Ointment
  5.2.4 Others
5.3 Market Segment by Type
  5.3.1 World Ophthalmic Cyclosporine Production by Type (2019-2030)
  5.3.2 World Ophthalmic Cyclosporine Production Value by Type (2019-2030)
  5.3.3 World Ophthalmic Cyclosporine Average Price by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Ophthalmic Cyclosporine Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Ophthalmic Cyclosporine Production by Application (2019-2030)
  6.3.2 World Ophthalmic Cyclosporine Production Value by Application (2019-2030)
  6.3.3 World Ophthalmic Cyclosporine Average Price by Application (2019-2030)

7 COMPANY PROFILES

7.1 Allergan
  7.1.1 Allergan Details
  7.1.2 Allergan Major Business
  7.1.3 Allergan Ophthalmic Cyclosporine Product and Services
  7.1.4 Allergan Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.1.5 Allergan Recent Developments/Updates
  7.1.6 Allergan Competitive Strengths & Weaknesses
7.2 Bausch + Lomb
  7.2.1 Bausch + Lomb Details
  7.2.2 Bausch + Lomb Major Business
  7.2.3 Bausch + Lomb Ophthalmic Cyclosporine Product and Services
  7.2.4 Bausch + Lomb Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.2.5 Bausch + Lomb Recent Developments/Updates
  7.2.6 Bausch + Lomb Competitive Strengths & Weaknesses
7.3 Teva
  7.3.1 Teva Details
  7.3.2 Teva Major Business
  7.3.3 Teva Ophthalmic Cyclosporine Product and Services
  7.3.4 Teva Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.3.5 Teva Recent Developments/Updates
  7.3.6 Teva Competitive Strengths & Weaknesses
7.4 Mylan Pharmaceuticals
  7.4.1 Mylan Pharmaceuticals Details
  7.4.2 Mylan Pharmaceuticals Major Business
  7.4.3 Mylan Pharmaceuticals Ophthalmic Cyclosporine Product and Services
  7.4.4 Mylan Pharmaceuticals Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.4.5 Mylan Pharmaceuticals Recent Developments/Updates
  7.4.6 Mylan Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Alcon
  7.5.1 Alcon Details
  7.5.2 Alcon Major Business
  7.5.3 Alcon Ophthalmic Cyclosporine Product and Services
  7.5.4 Alcon Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.5.5 Alcon Recent Developments/Updates
  7.5.6 Alcon Competitive Strengths & Weaknesses
7.6 Regenerx Biopharmaceuticals
  7.6.1 Regenerx Biopharmaceuticals Details
  7.6.2 Regenerx Biopharmaceuticals Major Business
  7.6.3 Regenerx Biopharmaceuticals Ophthalmic Cyclosporine Product and Services
  7.6.4 Regenerx Biopharmaceuticals Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.6.5 Regenerx Biopharmaceuticals Recent Developments/Updates
  7.6.6 Regenerx Biopharmaceuticals Competitive Strengths & Weaknesses
7.7 Mimetogen Pharmaceuticals
  7.7.1 Mimetogen Pharmaceuticals Details
  7.7.2 Mimetogen Pharmaceuticals Major Business
  7.7.3 Mimetogen Pharmaceuticals Ophthalmic Cyclosporine Product and Services
  7.7.4 Mimetogen Pharmaceuticals Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.7.5 Mimetogen Pharmaceuticals Recent Developments/Updates
  7.7.6 Mimetogen Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Mitotech
  7.8.1 Mitotech Details
  7.8.2 Mitotech Major Business
  7.8.3 Mitotech Ophthalmic Cyclosporine Product and Services
  7.8.4 Mitotech Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.8.5 Mitotech Recent Developments/Updates
  7.8.6 Mitotech Competitive Strengths & Weaknesses
7.9 Sun Pharma
  7.9.1 Sun Pharma Details
  7.9.2 Sun Pharma Major Business
  7.9.3 Sun Pharma Ophthalmic Cyclosporine Product and Services
  7.9.4 Sun Pharma Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.9.5 Sun Pharma Recent Developments/Updates
  7.9.6 Sun Pharma Competitive Strengths & Weaknesses
7.10 Otsuka Pharmaceutical
  7.10.1 Otsuka Pharmaceutical Details
  7.10.2 Otsuka Pharmaceutical Major Business
  7.10.3 Otsuka Pharmaceutical Ophthalmic Cyclosporine Product and Services
  7.10.4 Otsuka Pharmaceutical Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.10.5 Otsuka Pharmaceutical Recent Developments/Updates
  7.10.6 Otsuka Pharmaceutical Competitive Strengths & Weaknesses
7.11 Santen Pharmaceutical
  7.11.1 Santen Pharmaceutical Details
  7.11.2 Santen Pharmaceutical Major Business
  7.11.3 Santen Pharmaceutical Ophthalmic Cyclosporine Product and Services
  7.11.4 Santen Pharmaceutical Ophthalmic Cyclosporine Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.11.5 Santen Pharmaceutical Recent Developments/Updates
  7.11.6 Santen Pharmaceutical Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Ophthalmic Cyclosporine Industry Chain
8.2 Ophthalmic Cyclosporine Upstream Analysis
  8.2.1 Ophthalmic Cyclosporine Core Raw Materials
  8.2.2 Main Manufacturers of Ophthalmic Cyclosporine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Ophthalmic Cyclosporine Production Mode
8.6 Ophthalmic Cyclosporine Procurement Model
8.7 Ophthalmic Cyclosporine Industry Sales Model and Sales Channels
  8.7.1 Ophthalmic Cyclosporine Sales Model
  8.7.2 Ophthalmic Cyclosporine Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Ophthalmic Cyclosporine Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Ophthalmic Cyclosporine Production Value by Region (2019-2024) & (USD Million)
Table 3. World Ophthalmic Cyclosporine Production Value by Region (2025-2030) & (USD Million)
Table 4. World Ophthalmic Cyclosporine Production Value Market Share by Region (2019-2024)
Table 5. World Ophthalmic Cyclosporine Production Value Market Share by Region (2025-2030)
Table 6. World Ophthalmic Cyclosporine Production by Region (2019-2024) & (K Units)
Table 7. World Ophthalmic Cyclosporine Production by Region (2025-2030) & (K Units)
Table 8. World Ophthalmic Cyclosporine Production Market Share by Region (2019-2024)
Table 9. World Ophthalmic Cyclosporine Production Market Share by Region (2025-2030)
Table 10. World Ophthalmic Cyclosporine Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Ophthalmic Cyclosporine Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Ophthalmic Cyclosporine Major Market Trends
Table 13. World Ophthalmic Cyclosporine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Ophthalmic Cyclosporine Consumption by Region (2019-2024) & (K Units)
Table 15. World Ophthalmic Cyclosporine Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Ophthalmic Cyclosporine Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Ophthalmic Cyclosporine Producers in 2023
Table 18. World Ophthalmic Cyclosporine Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Ophthalmic Cyclosporine Producers in 2023
Table 20. World Ophthalmic Cyclosporine Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Ophthalmic Cyclosporine Company Evaluation Quadrant
Table 22. World Ophthalmic Cyclosporine Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Ophthalmic Cyclosporine Production Site of Key Manufacturer
Table 24. Ophthalmic Cyclosporine Market: Company Product Type Footprint
Table 25. Ophthalmic Cyclosporine Market: Company Product Application Footprint
Table 26. Ophthalmic Cyclosporine Competitive Factors
Table 27. Ophthalmic Cyclosporine New Entrant and Capacity Expansion Plans
Table 28. Ophthalmic Cyclosporine Mergers & Acquisitions Activity
Table 29. United States VS China Ophthalmic Cyclosporine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Ophthalmic Cyclosporine Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Ophthalmic Cyclosporine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Ophthalmic Cyclosporine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ophthalmic Cyclosporine Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Ophthalmic Cyclosporine Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Ophthalmic Cyclosporine Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Ophthalmic Cyclosporine Production Market Share (2019-2024)
Table 37. China Based Ophthalmic Cyclosporine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ophthalmic Cyclosporine Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Ophthalmic Cyclosporine Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Ophthalmic Cyclosporine Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Ophthalmic Cyclosporine Production Market Share (2019-2024)
Table 42. Rest of World Based Ophthalmic Cyclosporine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Ophthalmic Cyclosporine Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Ophthalmic Cyclosporine Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Ophthalmic Cyclosporine Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Ophthalmic Cyclosporine Production Market Share (2019-2024)
Table 47. World Ophthalmic Cyclosporine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Ophthalmic Cyclosporine Production by Type (2019-2024) & (K Units)
Table 49. World Ophthalmic Cyclosporine Production by Type (2025-2030) & (K Units)
Table 50. World Ophthalmic Cyclosporine Production Value by Type (2019-2024) & (USD Million)
Table 51. World Ophthalmic Cyclosporine Production Value by Type (2025-2030) & (USD Million)
Table 52. World Ophthalmic Cyclosporine Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Ophthalmic Cyclosporine Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Ophthalmic Cyclosporine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Ophthalmic Cyclosporine Production by Application (2019-2024) & (K Units)
Table 56. World Ophthalmic Cyclosporine Production by Application (2025-2030) & (K Units)
Table 57. World Ophthalmic Cyclosporine Production Value by Application (2019-2024) & (USD Million)
Table 58. World Ophthalmic Cyclosporine Production Value by Application (2025-2030) & (USD Million)
Table 59. World Ophthalmic Cyclosporine Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Ophthalmic Cyclosporine Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Allergan Basic Information, Manufacturing Base and Competitors
Table 62. Allergan Major Business
Table 63. Allergan Ophthalmic Cyclosporine Product and Services
Table 64. Allergan Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Allergan Recent Developments/Updates
Table 66. Allergan Competitive Strengths & Weaknesses
Table 67. Bausch + Lomb Basic Information, Manufacturing Base and Competitors
Table 68. Bausch + Lomb Major Business
Table 69. Bausch + Lomb Ophthalmic Cyclosporine Product and Services
Table 70. Bausch + Lomb Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Bausch + Lomb Recent Developments/Updates
Table 72. Bausch + Lomb Competitive Strengths & Weaknesses
Table 73. Teva Basic Information, Manufacturing Base and Competitors
Table 74. Teva Major Business
Table 75. Teva Ophthalmic Cyclosporine Product and Services
Table 76. Teva Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Teva Recent Developments/Updates
Table 78. Teva Competitive Strengths & Weaknesses
Table 79. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Mylan Pharmaceuticals Major Business
Table 81. Mylan Pharmaceuticals Ophthalmic Cyclosporine Product and Services
Table 82. Mylan Pharmaceuticals Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Mylan Pharmaceuticals Recent Developments/Updates
Table 84. Mylan Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Alcon Basic Information, Manufacturing Base and Competitors
Table 86. Alcon Major Business
Table 87. Alcon Ophthalmic Cyclosporine Product and Services
Table 88. Alcon Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Alcon Recent Developments/Updates
Table 90. Alcon Competitive Strengths & Weaknesses
Table 91. Regenerx Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Regenerx Biopharmaceuticals Major Business
Table 93. Regenerx Biopharmaceuticals Ophthalmic Cyclosporine Product and Services
Table 94. Regenerx Biopharmaceuticals Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Regenerx Biopharmaceuticals Recent Developments/Updates
Table 96. Regenerx Biopharmaceuticals Competitive Strengths & Weaknesses
Table 97. Mimetogen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Mimetogen Pharmaceuticals Major Business
Table 99. Mimetogen Pharmaceuticals Ophthalmic Cyclosporine Product and Services
Table 100. Mimetogen Pharmaceuticals Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Mimetogen Pharmaceuticals Recent Developments/Updates
Table 102. Mimetogen Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Mitotech Basic Information, Manufacturing Base and Competitors
Table 104. Mitotech Major Business
Table 105. Mitotech Ophthalmic Cyclosporine Product and Services
Table 106. Mitotech Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Mitotech Recent Developments/Updates
Table 108. Mitotech Competitive Strengths & Weaknesses
Table 109. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Sun Pharma Major Business
Table 111. Sun Pharma Ophthalmic Cyclosporine Product and Services
Table 112. Sun Pharma Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Sun Pharma Recent Developments/Updates
Table 114. Sun Pharma Competitive Strengths & Weaknesses
Table 115. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Otsuka Pharmaceutical Major Business
Table 117. Otsuka Pharmaceutical Ophthalmic Cyclosporine Product and Services
Table 118. Otsuka Pharmaceutical Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Otsuka Pharmaceutical Recent Developments/Updates
Table 120. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 121. Santen Pharmaceutical Major Business
Table 122. Santen Pharmaceutical Ophthalmic Cyclosporine Product and Services
Table 123. Santen Pharmaceutical Ophthalmic Cyclosporine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Global Key Players of Ophthalmic Cyclosporine Upstream (Raw Materials)
Table 125. Ophthalmic Cyclosporine Typical Customers
Table 126. Ophthalmic Cyclosporine Typical Distributors

LIST OF FIGURE

Figure 1. Ophthalmic Cyclosporine Picture
Figure 2. World Ophthalmic Cyclosporine Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Ophthalmic Cyclosporine Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Ophthalmic Cyclosporine Production (2019-2030) & (K Units)
Figure 5. World Ophthalmic Cyclosporine Average Price (2019-2030) & (US$/Unit)
Figure 6. World Ophthalmic Cyclosporine Production Value Market Share by Region (2019-2030)
Figure 7. World Ophthalmic Cyclosporine Production Market Share by Region (2019-2030)
Figure 8. North America Ophthalmic Cyclosporine Production (2019-2030) & (K Units)
Figure 9. Europe Ophthalmic Cyclosporine Production (2019-2030) & (K Units)
Figure 10. China Ophthalmic Cyclosporine Production (2019-2030) & (K Units)
Figure 11. Japan Ophthalmic Cyclosporine Production (2019-2030) & (K Units)
Figure 12. Ophthalmic Cyclosporine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 15. World Ophthalmic Cyclosporine Consumption Market Share by Region (2019-2030)
Figure 16. United States Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 17. China Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 18. Europe Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 19. Japan Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 20. South Korea Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 22. India Ophthalmic Cyclosporine Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Ophthalmic Cyclosporine by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ophthalmic Cyclosporine Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ophthalmic Cyclosporine Markets in 2023
Figure 26. United States VS China: Ophthalmic Cyclosporine Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Ophthalmic Cyclosporine Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Ophthalmic Cyclosporine Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Ophthalmic Cyclosporine Production Market Share 2023
Figure 30. China Based Manufacturers Ophthalmic Cyclosporine Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Ophthalmic Cyclosporine Production Market Share 2023
Figure 32. World Ophthalmic Cyclosporine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Ophthalmic Cyclosporine Production Value Market Share by Type in 2023
Figure 34. Ophthalmic Cyclosporine Emulsion
Figure 35. Ophthalmic Cyclosporine Suspension
Figure 36. Ophthalmic Cyclosporine Ointment
Figure 37. Others
Figure 38. World Ophthalmic Cyclosporine Production Market Share by Type (2019-2030)
Figure 39. World Ophthalmic Cyclosporine Production Value Market Share by Type (2019-2030)
Figure 40. World Ophthalmic Cyclosporine Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Ophthalmic Cyclosporine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Ophthalmic Cyclosporine Production Value Market Share by Application in 2023
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Others
Figure 46. World Ophthalmic Cyclosporine Production Market Share by Application (2019-2030)
Figure 47. World Ophthalmic Cyclosporine Production Value Market Share by Application (2019-2030)
Figure 48. World Ophthalmic Cyclosporine Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Ophthalmic Cyclosporine Industry Chain
Figure 50. Ophthalmic Cyclosporine Procurement Model
Figure 51. Ophthalmic Cyclosporine Sales Model
Figure 52. Ophthalmic Cyclosporine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source


More Publications